anmelden
25 € WM-Startbonus + 5 € Torbonus für jeden deutschen Treffer*
OMX Nordic 40
2.663,51
PKT
-29,19
PKT
-1,08
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 07.12.21 | Volvo (B) Sell | UBS AG | |
| 07.12.21 | ABB (Asea Brown Boveri) Buy | UBS AG | |
| 07.12.21 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 07.12.21 | ABB (Asea Brown Boveri) Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 07.12.21 | Novo Nordisk Buy | Deutsche Bank AG | |
| 07.12.21 | ABB (Asea Brown Boveri) Outperform | Bernstein Research | |
| 07.12.21 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 07.12.21 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 07.12.21 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 03.12.21 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 03.12.21 | Kone Overweight | JP Morgan Chase & Co. | |
| 03.12.21 | Alfa Laval Underweight | JP Morgan Chase & Co. | |
| 02.12.21 | Nokia Buy | Goldman Sachs Group Inc. | |
| 02.12.21 | Hennes Mauritz (H M, H&M) Outperform | RBC Capital Markets | |
| 01.12.21 | Nokia Overweight | JP Morgan Chase & Co. | |
| 01.12.21 | Hennes Mauritz (H M, H&M) Overweight | Barclays Capital | |
| 01.12.21 | Kone Buy | Jefferies & Company Inc. | |
| 29.11.21 | Novo Nordisk Buy | Deutsche Bank AG | |
| 29.11.21 | A.P. Moeller - Maersk A-S (B) Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 26.11.21 | Novo Nordisk Neutral | UBS AG | |
| 26.11.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 26.11.21 | Novo Nordisk Outperform | Bernstein Research | |
| 24.11.21 | Kone Neutral | Goldman Sachs Group Inc. | |
| 24.11.21 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 22.11.21 | Ericsson (Telefon L.M.Ericsson) (B) Outperform | Credit Suisse Group | |
| 22.11.21 | AstraZeneca Buy | Kepler Cheuvreux | |
| 22.11.21 | Novo Nordisk Overweight | Barclays Capital | |
| 19.11.21 | Novo Nordisk Neutral | UBS AG | |
| 18.11.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 17.11.21 | AstraZeneca Buy | Deutsche Bank AG | |
| 17.11.21 | AstraZeneca Buy | UBS AG | |
| 15.11.21 | AstraZeneca Buy | Deutsche Bank AG | |
| 15.11.21 | AstraZeneca Outperform | Credit Suisse Group | |
| 15.11.21 | A.P. Moeller - Maersk A-S (B) Neutral | JP Morgan Chase & Co. | |
| 12.11.21 | AstraZeneca Buy | UBS AG | |
| 12.11.21 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 12.11.21 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 12.11.21 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 11.11.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 10.11.21 | Nokia Buy | UBS AG |